The Obstetrician & Gynaecologist 2009;11:1:41-47
doi: 10.1576/toag.11.1.41.27467
Copyright © 2009 by the Royal College of Obstetricians and Gynaecologists.
Adenomyosis uteri: an update
Mohamed K Mehasseb, MSc MD MRCOG, Clinical Research Fellow and Specialist Registrar in Obstetrics and Gynaecology1 and
Marwan A Habiba, MSc PhD FRCOG, Senior Lecturer and Consultant in Obstetrics and Gynaecology2
1. Reproductive Sciences Section — Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK Email: mkm7{at}le.ac.uk (corresponding author)
2. Reproductive Sciences Section — Department of Cancer Studies and Molecular Medicine, University of Leicester, UK
Key content:
- Adenomyosis uteri is defined by the presence of endometrium in the myometrium.
- The prevalence in asymptomatic women remains unknown.
- It is commonly associated with other pathologies.
- Hysterectomy remains the main surgical option for women whose families are complete.
Learning objectives:
- To understand the theories regarding the aetiology.
- To appreciate the clinical picture and complications.
- To learn about current treatment modalities.
Ethical issues:
- Counselling women with adenomyosis uteri is challenging when the clinical significance of the condition is uncertain.
- Are more expensive diagnostic tests, such as magnetic resonance imaging, justifiable?
- Is the risk–benefit weighted against invasive investigation?
Please cite this article as: Mehasseb MK and Habiba MA. Adenomyosis uteri: an update. The Obstetrician & Gynaecologist 2009;11:41–47.
Keywords endometrial–myometrial interface / endomyometrial ablation / hysterectomy / magnetic resonance imaging (MRI)
Copyright © 2009 by the Royal College of Obstetricians and Gynaecologists.